✦ LIBER ✦

Selective Urokinase-Type Plasminogen Activator (uPA) Inhibitors. Part 3. 1-Isoquinolinylguanidines.

✍ Scribed by Christopher G. Barber; Roger P. Dickinson; Paul V. Fish

Publisher: John Wiley and Sons
Year: 2004
Weight: 18 KB
Volume: 35
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200440143

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Selective Urokinase

ChemInform Abstract: Selective Urokinase-Type Plasminogen Activator (uPA) Inhibitors. Part 1. 2-Pyridinylguanidines.

✍ Christopher G. Barber; Roger P. Dickinson; Valerie A. Horne 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 28 KB

ChemInform Abstract: Selective Urokinase

ChemInform Abstract: Selective Urokinase-Type Plasminogen Activator (uPA) Inhibitors. Part 2. (3-Substituted-5-halo-2-pyridinyl)guanidines.

✍ Christopher G. Barber; Roger P. Dickinson 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 30 KB

ELISA for complexes of urokinase-type an

ELISA for complexes of urokinase-type and tissue-type plasminogen activators with their type-1 inhibitor (uPA∼PAI-1 and tPA∼PAI-1)

✍ Nicolai Grebenschikov; Fred Sweep; Anneke Geurts; Peter Andreasen; Hans De Witte 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 125 KB 👁 1 views

An ELISA has been developed for the assessment of complexes between the urokinase-type (uPA) and the tissuetype plasminogen (tPA) activators with their inhibitor type-1 (PAI-1) in cell-culture medium and cytosolic extracts of breast tumours. The ''4-stage/2-site'' ELISA involves 2 polyclonal antibod

2-(2-Hydroxy-3-alkoxyphenyl)-1H-benzimid

2-(2-Hydroxy-3-alkoxyphenyl)-1H-benzimidazole-5-carboxamidine Derivatives as Potent and Selective Urokinase-Type Plasminogen Activator Inhibitors.

✍ Richard L. Mackman; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB 👁 1 views

Mutational analysis of the genes encodin

Mutational analysis of the genes encoding urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in advanced ovarian cancer

✍ Beyhan Türkmen; Manfred Schmitt; Barbara Schmalfeldt; Paul Trommler; Wolfgang He 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 469 KB 👁 1 views

Transforming growth factor β1, urokinase

Transforming growth factor β1, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in head and neck squamous carcinoma and normal adjacent mucosa

✍ Fatima S. Pasini; M. Mitzi Brentani; Luiz P. Kowalski; Miriam H. H. Federico 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 1 views

## Background: A balance between urokinase-type plasminogen activator (upa) and its main inhibitor type-1 (pai-1) appears to be important for cancer invasive behavior. since upa/pai-1 system seems to be regulated by transforming growth factor beta1 (tgfbeta1) in different cell types, our aim was to